Performance analysis of Corbus Pharmaceuticals (CRBP)
Annual Return
Over the past 3 years, CRBP has had an average annual return of -8.52%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, CRBP has had an average annual return of -33.88%, underperforming the benchmark SPY, which returned +14.05% annual.
Over the past 10 years, CRBP has had an average annual return of -23.69%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Nov 11, 2014, CRBP has had an average annual return of -19.30%, underperforming the benchmark SPY, which returned +13.94% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.30% | -31.05% | +95.38% | +82.34% | -82.07% | -50.76% | -77.10% | -6.51% | -17.75% | -15.98% | +412.13% | -44.82% |
| 2014 | |||||||||||
| -0.33% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.66% | +3.59% | +9.56% | +5.27% | -19.95% | -4.66% | -7.30% | ||||||
| 2025 | -17.01% | -22.89% | -29.68% | +40.68% | -0.72% | -6.92% | +34.29% | +1.07% | +35.06% | -3.98% | -5.04% | -29.49% | -31.05% |
| 2024 | +338.60% | +16.65% | +27% | -5.60% | +15.55% | +5.72% | +31.42% | +2.88% | -66.28% | -22.64% | +11.68% | -33.79% | +95.38% |
| 2023 | +40.49% | -35.78% | +143.37% | +20.79% | +7.79% | -17.21% | -8.15% | +1.38% | -7.64% | -19.09% | +22.61% | -9.69% | +82.34% |
| 2022 | -28.51% | -21.40% | +53.69% | -36.29% | -10.45% | -16.82% | +0.36% | -20.38% | -18.15% | -21.27% | +49.65% | -43.21% | -82.07% |
| 2021 | +46.39% | +19.13% | -9.63% | -8.63% | +20.55% | -15.66% | -25.13% | -5.85% | -20.93% | -1.97% | -13.65% | -28.70% | -50.76% |
| 2020 | +18.50% | -26.74% | +10.55% | +23.66% | +15.12% | +12.47% | -25.27% | +48.09% | -80.61% | -47.80% | +29.85% | +2.46% | -77.10% |
| 2019 | +29.45% | -8.20% | +0.15% | +2.73% | -1.82% | -1.14% | -13.42% | -13.66% | -5.99% | +6.16% | -9.09% | +16.17% | -6.51% |
| 2018 | +5.63% | -1.33% | -17.57% | -2.46% | +4.21% | -18.55% | -0% | +15.84% | +29.06% | -11.79% | +3.60% | -15.36% | -17.75% |
| 2017 | -20.71% | +27.61% | -3.51% | -12.73% | -13.89% | +1.61% | -5.56% | +30.25% | -7.74% | -0.70% | +8.45% | -7.79% | -15.98% |
Drawdown analysis of Corbus Pharmaceuticals (CRBP)
The maximum drawdown for the CRBP was -99.31%, occurring on Mar 10, 2023. This drawdown has not yet recovered.
The current CRBP drawdown is -97.57%.
Since Nov 11, 2014 CRBP has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 4 times
- 20% or more: 4 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.31% | Mar 20, 2017 | 1504 | Mar 10, 2023 | Ongoing | Ongoing | Ongoing |
| -78.79% | Dec 5, 2014 | 296 | Feb 10, 2016 | 146 | Sep 8, 2016 | 442 |
| -50.97% | Oct 7, 2016 | 19 | Nov 3, 2016 | 92 | Mar 20, 2017 | 111 |
| -34.45% | Nov 13, 2014 | 7 | Nov 24, 2014 | 8 | Dec 5, 2014 | 15 |
| -17.44% | Sep 19, 2016 | 4 | Sep 23, 2016 | 8 | Oct 5, 2016 | 12 |
| -1.81% | Oct 5, 2016 | 1 | Oct 6, 2016 | 1 | Oct 7, 2016 | 2 |